Status:
COMPLETED
Follow Fever to Decide
Lead Sponsor:
Slb Pharma
Collaborating Sponsors:
Université de Caen Normandie
Capital Innovation
Conditions:
Body Temperature Changes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Body temperature is one of the markers of biological rhythms. The precise determination of the functioning of the biological clock for an individual is essential to understanding his physiological sta...
Detailed Description
While the measurement of body temperature is one of the first self-diagnosis gestures at home, it is unanimously agreed by healthcare professionals that the measurement of non-invasive body temperatur...
Eligibility Criteria
Inclusion
- Healthy male or female,
- Between 18 and 40 years of age for the WP I and II phases, and between 18 and 80 years of age for the WP III phase,
- Having an BMI within the range \[18.5; 24.9\] kg/m² for the Work Package I and II phases, and between \[18.5; 34.9\] kg/m² for the Work Package III phase,
- Beneficiary of the social security,
- Provided informed consent for participation in the study.
Exclusion
- Presenting an acute pathology,
- Chronic pathology not followed and balanced,
- Having intestinal disorders (diverticles, disorders of the motility of the digestive tract, ...) or having undergone surgery at the gastrointestinal level,
- With known swallowing disorders,
- Having an alcohol dependence (more than 28 alcohol units per week), benzodiazepines or any illicit product,
- Smoking more than 5 cigarettes per day,
- Working nights or shift work,
- Simultaneous participation in other clinical research or participation in another clinical study for which the exclusion period has not ended.
Key Trial Info
Start Date :
March 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2021
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT04311268
Start Date
March 13 2020
End Date
December 18 2021
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire COMETE UMR-S 1075
Caen, France, 14000